Fabiola Porta has studied Medicinal Chemistry and Pharmaceutical Technology in Milan from the Universita’ degli studi, where she obtained her Master’s degree in Pharmacy in the year 2008. She then moved to the Leiden Institute of Chemistry, where she graduated in Chemistry with a special focus on nanoparticles synthesis and characterization in the year 2012. She has done her post-doctoral studies from FHNW and University of Basel. Recently, she joined the group of Bio-pharmacy, where she is developing-self assembled nanoparticles for cancer therapy. She has expertise in the design and development of nano-vehicles for cancer therapy with a particular focus on targeted nanocarriers for breast cancer therapy Fabiola Porta has studied Medicinal Chemistry and Pharmaceutical Technology in Milan from the Universita’ degli studi, where she obtained her Master’s degree in Pharmacy in the year 2008. She then moved to the Leiden Institute of Chemistry, where she graduated in Chemistry with a special focus on nanoparticles synthesis and characterization in the year 2012. She has done her post-doctoral studies from FHNW and University of Basel. Recently, she joined the group of Bio-pharmacy, where she is developing-self assembled nanoparticles for cancer therapy. She has expertise in the design and development of nano-vehicles for cancer therapy with a particular focus on targeted nanocarriers for breast cancer therapy

Medicinal chemistry